Issues in the diagnosis and management of essential thrombocythemia (Q40663379)

22 September 2017

1 reference

title

Issues in the diagnosis and management of essential thrombocythemia (English)

1 reference

22 September 2017

1

A Tefferi

1 reference

22 September 2017

H C Hoagland

2

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 July 1994

1 reference

22 September 2017

1 reference

22 September 2017

volume

69

1 reference

22 September 2017

issue

7

1 reference

22 September 2017

page(s)

651-655

1 reference

Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Acute leukemia with abnormal thrombopoiesis and inversions of chromosome 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Uncontrolled thrombocytosis in chronic myeloproliferative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Thrombocytosis in adults: analysis of 777 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Life expectancy of patients with chronic nonleukemic myeloproliferative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Marrow transplantation for the treatment of chronic myelogenous leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Clinical course of essential thrombocythemia in 147 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Interleukin-6 in clinical medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Serum levels of interleukin-6 and acute phase responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Elevated serum interleukin-6 levels in patients with reactive thrombocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Primary thrombocythaemia: diagnostic criteria and a simple scoring system for positive diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Cytogenetic studies on primary thrombocythaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Controlled and uncontrolled thrombocytosis. Its clinical role in essential thrombocythemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Acute leukemia as a natural sequel to primary thrombocythemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Skin changes secondary to hydroxyurea therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. Anagrelide Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

A long-term clinical trial of interferon alpha-therapy in essential thrombocythemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

The treatment of essential thrombocythaemia with radioactive phosphorus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Essential thrombocythemia in young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Thrombocytosis in young people: evaluation of 57 cases diagnosed before the age of 40

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Hemostatic complications in young patients with essential thrombocythemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Clinical manifestations of essential thrombocythemia in young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

Primary thrombocythaemia in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961342-1

10.1016/S0025-6196(12)61342-1

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference